Hot Investor Mandate: VC Fund Focuses Investments on Medical Devices, Therapeutics, and Diagnostics Companies Looking to Expand to the China Market

25 Oct

A VC fund is focused on the earliest stage companies looking to expand to the Chinese market. The firm will invest between $50-250K in companies that are preclinical/in development and looks to be a strategic partner, either by helping the company enter the Chinese market, or find a licensing opportunity with one of the firm’s strategic partners in China. The firm is looking for therapeutic, medical device or diagnostics companies, but will generally not consider digital health companies due to the difficulty in adapting them to the Chinese market. The firm is currently looking to make about 4 investments a year, about 1 per quarter.

The firm is currently focused primarily on medical devices, but will consider therapeutics and diagnostics as well. For medical devices, the firm prefers 510k pathway. The firm is generally agnostic to subsector and indication, but is seeking technologies that are relevant to the Chinese market.

While it is not required, the firm prefers to take a board seat after investing, since they are looking to be active strategic partners in each company in which the firm invests.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: